Source: FirstWord Pharma

STEMCELL: SQZ Biotechnologies Announces First Data Presentation on Non-Clinical Studies of Point-of-Care Manufacturing System and Collaboration with STEMCELL Technologies on Research-Use-Only System to Fuel Preclinical Research

SQZ's Point-of-Care (POC) Manufacturing Platform Shows Promising Results with Ability to Produce Cell Therapies at Scale in Under 10 Hours Co-Development of Research-Use-Only System with STE...

Read full article »
Est. Annual Revenue
$100-500M
Agree?
Est. Employees
1.0-5.0K
Agree?
Allen Eaves's photo - President & CEO of STEMCELL

President & CEO

Allen Eaves

CEO Approval Rating

98/100

Read more